Video | 03 February 2021 New findings: a gamechanger for diabetes care in refugee settings 1 min DIABETES Read, watch, share Filter by - Any -BlogFeature storyIssue briefLetterPress releaseReport seriesResearch articleStatementTechnical briefVideo Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Anis Al-Bahash 5 min Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Amina 6 min Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Ghassan Fakhri Jabar 7 min Feature story Feature story | 01 November 2024 Diabetes Greece Migrating while managing diabetes: why access to insulin in pens must be available to everyone 2 min Photo credit: Jinane Saad/MSF Press release Press release | 26 September 2024 Diabetes MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens 5 min Letter | 23 September 2024 Diabetes Open letter to Eli Lilly on barriers to accessing diabetes medicines Letter | 23 September 2024 Diabetes Open letter to Sanofi on barriers to accessing diabetes medicines Photo credit: Carmen Yahchouchi/MSF Press release Press release | 23 September 2024 Diabetes Ahead of US Senate hearing, MSF calls on pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi to make essential diabetes medicines affordable and accessible 4 min Load More
Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Anis Al-Bahash 5 min
Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Amina 6 min
Feature story Feature story | 01 November 2024 Diabetes Greece My journey to Europe with diabetes: Ghassan Fakhri Jabar 7 min
Feature story Feature story | 01 November 2024 Diabetes Greece Migrating while managing diabetes: why access to insulin in pens must be available to everyone 2 min
Photo credit: Jinane Saad/MSF Press release Press release | 26 September 2024 Diabetes MSF calls out Novo Nordisk for its double standard approach to diabetes, as corporation plans to halt supply of human insulin pens 5 min
Letter | 23 September 2024 Diabetes Open letter to Eli Lilly on barriers to accessing diabetes medicines
Letter | 23 September 2024 Diabetes Open letter to Sanofi on barriers to accessing diabetes medicines
Photo credit: Carmen Yahchouchi/MSF Press release Press release | 23 September 2024 Diabetes Ahead of US Senate hearing, MSF calls on pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi to make essential diabetes medicines affordable and accessible 4 min
